<DOC>
	<DOCNO>NCT01536483</DOCNO>
	<brief_summary>Clinical management low birth weight newborn ( VLBW &lt; 1250g ) consist several challenge adapt immature physiological system extrauterine life . Advances neonatal medicine pulmonary and/or neurological and/or cardiovascular diseases significantly improve outcomes child . However , gastro-intestinal ( GI ) tract remain major cause morbidity due 1. immaturity GI function ( prolonged ileus , bacterial overgrowth translocation ) , 2. complication GI tract immaturity : intestinal perforation enterocolitis necrotizing ) 3. need prolong parenteral nutrition complication ( central venous catheter infection , sepsis , electrolyte disturbance ) without generate high proof level target population ( &lt; 1250g ) . The GI function progressively acquire development largely sensitive environment , especially intestinal luminal content . Indeed , probiotic prebiotics show beneficial effect upon GI function newborns . One metabolite gut flora potentially involved butyrate . Butyrate short chain fatty acid produce colon microbiota ( carbo-hydrates degradation ) . The colonic amount butyrate increase gradually birth . The beneficial effect butyrate relate property upon epithelial barrier ( anti-inflammatory , antioxidant , barrier repair ) upon enteric nervous system ( network neuron glial cell ) regulate GI function particular colonic motility . To date , clinical consensus manage digestive disorder VLBW . Several clinical study assess effect prokinetic drug , dietary supplement ( probiotic , prebiotics ) without generate high proof level target population . In context , recent study Research Unit ( INSERM-CIC MÃ¨re-Enfant 004 ) show benefit effect oral probiotic supplementation child birth weight great 1000g extreme preterms birth weight less 1000g . The main hypothesis explain thesis result lie intensive use antibiotic feeding interruption frequency target population induce disturbance composition gut lumen ( particular flora ) . Colonic enema assess various observational study concern VLBW seem demonstrate clinical efficiency upon colonic transit , underlie mechanical osmotic mechanism . Here , investigator propose evaluate clinical efficiency butyrate enema prospective randomize clinical trial blind design . The purpose NEOTRANS study demonstrate butyrate enema may improve nutritional management extreme preterm less 1250 gram , facilitate development colic motility clinical nutrition tolerance .</brief_summary>
	<brief_title>Effects Recto-colic Enemas Butyrate Digestive Disorders Very Low Birth Weight Preterms &lt; 1250 Grams</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Butyric Acid</mesh_term>
	<criteria>Any preterm infant birth weight less equal 1250 gram admit neonatal intensive care unit Nantes Hospital Inborn outborn No sign gastrointestinal perforation ECUN Absence severe congenital disease Written inform consent parental authority . Newborn birth weight great 1250 gram , Gestational age &gt; 30 AG Digestive pathology diagnose prior PND5 : perforation , necrotizing enterocolitis , malformation Severe congenital pathology inconsistent clinical assessment . Parental Refusal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Days</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Butyrate</keyword>
	<keyword>Preterms</keyword>
	<keyword>Very Low Birth Weight ( &lt; 1250g )</keyword>
	<keyword>Rectocolonic enema</keyword>
	<keyword>Digestive maturation</keyword>
	<keyword>Parenteral nutrition wean</keyword>
	<keyword>ECUN</keyword>
	<keyword>Whole gut transit time</keyword>
</DOC>